» Articles » PMID: 23416207

γH2AX As a Marker of DNA Double Strand Breaks and Genomic Instability in Human Population Studies

Overview
Journal Mutat Res
Publisher Elsevier
Specialty Genetics
Date 2013 Feb 19
PMID 23416207
Citations 105
Authors
Affiliations
Soon will be listed here.
Abstract

DNA double strand breaks (DSB) are the gravest form of DNA damage in eukaryotic cells. Failure to detect DSB and activate appropriate DNA damage responses can cause genomic instability, leading to tumorigenesis and possibly accelerated aging. Phosphorylated histone H2AX (γH2AX) is used as a biomarker of cellular response to DSB and its potential for monitoring DNA damage and repair in human populations has been explored in this review. A systematic search was conducted in PubMed for articles, in English, on human studies reporting γH2AX as a biomarker of either DNA repair or DNA damage. A total of 68 publications were identified. Thirty-four studies (50.0%) evaluated the effect of medical procedures or treatments on γH2AX levels; 20 (29.4%) monitored γH2AX in specific pathological conditions with a case/control or case/case design; 5 studies (7.4%) evaluated the effect of environmental genotoxic exposures, and 9 (13.2%) were descriptive studies on cancer and aging. Peripheral blood lymphocytes (44.6%) or biopsies/tissue specimens (24.3%) were the most commonly used samples. γH2AX was scored by optical microscopy as immunostained foci (78%), or by flow cytometry (16%). Critical features affecting the reliability of the assay, including protocols heterogeneity, specimen, cell cycle, kinetics, study design, and statistical analysis, are hereby discussed. Because of its sensitivity, efficiency and mechanistic relevance, the γH2AX assay has great potential as a DNA damage biomarker; however, the technical and epidemiological heterogeneity highlighted in this review infer a necessity for experimental standardization of the assay.

Citing Articles

Unveiling the geroprotective potential of Monarda didyma L.: insights from in vitro studies and a randomized clinical trial on slowing biological aging and improving quality of life.

Campisi M, Cannella L, Paccagnella O, Brazzale A, Agnolin A, Grothe T Geroscience. 2025; .

PMID: 40064804 DOI: 10.1007/s11357-025-01580-2.


Radioprotection of healthy tissue via nanoparticle-delivered mRNA encoding for a damage-suppressor protein found in tardigrades.

Kirtane A, Bi J, Rajesh N, Tang C, Jimenez M, Witt E Nat Biomed Eng. 2025; .

PMID: 40011582 DOI: 10.1038/s41551-025-01360-5.


IHCH9033, a novel class I HDAC inhibitor, synergizes with FLT3 inhibitor and rescues quizartinib resistance in FLT3-ITD AML via enhancing DNA damage response.

Yao M, Yan W, Wang Y, Zhao Y, Xu X, Chen Y Exp Hematol Oncol. 2025; 14(1):15.

PMID: 39955584 PMC: 11829435. DOI: 10.1186/s40164-025-00605-y.


Celastrol attenuates the invasion and migration and augments the anticancer effects of olaparib in prostate cancer.

Huang M, Chen L, Ma X, Xu H Cancer Cell Int. 2024; 24(1):352.

PMID: 39462410 PMC: 11514812. DOI: 10.1186/s12935-024-03542-8.


NAD depletion is central to placental dysfunction in an inflammatory subclass of preeclampsia.

Jahan F, Vasam G, Cariaco Y, Nik-Akhtar A, Green A, Menzies K Life Sci Alliance. 2024; 7(12).

PMID: 39389781 PMC: 11467044. DOI: 10.26508/lsa.202302505.